1Jordan CT,Guzman ML,Noble M. Cancer stem cells[J]. N Engl J Med,2006,355(12) :1253-1261.
2Eyler CE,Rich JN. Survival of the fittest :cancer stem cells in thera- peutic resistance and angiogenesis[J]. J Clin Oncol, 2008,26 (17) 2839-2845.
3Merlo LM,Pepper JW, Reid BJ, et aI. Cancer as an evolutionary and ecological process [J]. Nat Rev Cancer, 2006,6 (12) : 924- 935.
4Al-Hajj M,Wicha MS,Benito-Hernandez A,et al. Prospective i- dentification of tumorigenic breast cancer cells [J]. Proc Natl Acad Sci U S A,2003,100(7):3983-3988.
5Abbott A. Cancer:the root of the problem[J]. Nature, 2006,442 (7104) :742-743.
6Fillmore CM,Kuperwasser C. Human breast cancer cell lines contain stem-like cells tb.at self-renew, give rise to pb.enotypically diverse progeny and survive chemotherapy[J]. Breast Cancer Res, 2008,10 (2):R25.
7Li X, Lewis MT, Huang J, et al. Intrinsic resistance of tumori- genic breast cancer cells to chemotherapy[J]. J Natl Cancer Inst, 2008,100(9) : 672-679.
8Sheridan C, Kishimoto H, Fuchs RK, et al. CD44+/CD24-- breast cancer cells exhibit enhanced invasive properties: an early step neces- sary for metastasis[J]. Breast Cancer Res, 2006,8 (5) : R59.
9Balic M, Lin H, Young L, et al. Most early disseminated cancer cells detected in bone marrow of breast cancer patients have a putative breast cancer stem cell phenotype[J]. Clin Cancer Res, 2006,12(19) :5615-5621.
10Abraham BK,Fritz P,McClellan M,et al. Prevalence of CD44+/ CD24-/low cells in breast cancer may not be associated with clinical outcome hut may favor distant metastasis[J]. Clin Cancer Res,2005,11(3) : 1154-1159.
